Overview

Extension Study, Pilot, Compassionate Use of Azacitidine 300 Mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients

Status:
NOT_YET_RECRUITING
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
Extension study, pilot, single-arm, compassionate use of Hikma Azacitidine 300 mg Film coated tablets test product for the Acute Myeloid Leukaemia (AML) patients who completed Hikma bioequivalence study with protocol number: HIK-AZA-2023-01
Phase:
NA
Details
Lead Sponsor:
Hikma Pharmaceuticals LLC
Treatments:
Azacitidine